✨ Free AI Report
Beckman Coulter, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Beckman Coulter, Inc.
Company Research

Beckman Coulter, Inc.: Business Overview, Financials & Competitive Analysis

Beckman Coulter, Inc. is a biomedical testing instrument manufacturer and a subsidiary of Danaher Corporation since 2011. The company develops, manufactures, and markets diagnostic and life sciences products including...

Analyst-debate audio for Beckman Coulter, Inc.

AskCyborg analysts argue the bull and bear cases for Beckman Coulter, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Established market leader in biomedical diagnostics with diversified product portfolio, backed by Danaher's operational...

Read the full analyst-debate transcript →
Industry In-Vitro Diagnostics
5 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Beckman Coulter, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Beckman Coulter, Inc. Overview

Pro stress-test →

Beckman Coulter, Inc. is a biomedical testing instrument manufacturer and a subsidiary of Danaher Corporation since 2011. The company develops, manufactures, and markets diagnostic and life sciences products including instruments, reagents, automation systems, and related clinical information management tools used across core disciplines such as chemistry, immunoassay, hematology, microbiology, and flow cytometry.

Strategic Profile

Pro stress-test →

As part of Danaher's Life Sciences & Diagnostics segment, Beckman Coulter leverages the Danaher Business System for accelerated innovation and operational excellence. The company maintains market leadership through a diversified product portfolio addressing hospital laboratories, clinical diagnostics, pharmaceutical research, and biomedical research globally, with approximately 12,000+ employees and $5.8 billion in annual sales.

Competitive Landscape

Pro stress-test →

Beckman Coulter competes in the global biomedical diagnostics and life sciences market alongside major players including Cepheid, Sartorius, Agilent Technologies, Illumina, and Horizon Discovery. The company differentiates through its integrated systems approach (instruments + consumables + software + services), broad menu of tests (150+ tests per system), and Danaher's operational capabilities. It ranks among top competitors in its market segment with strong positioning in automation and chemistry disciplines.

Industry Context

Beckman Coulter, Inc. operates in In-Vitro Diagnostics.

Key facts

Founded: 1935 · Headquarters: Brea, US · Employees: 12,000+ · Revenue: $5.8B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Beckman Coulter, Inc..

  • Subsidiary of Danaher Corporation since June 2011, providing access to world-class operational systems and technology platforms across the Life Sciences & Diagnostics segment
  • Over 12,000 employees globally with established distribution in approximately 130 countries, generating approximately $5.8 billion in annual sales with recurring revenue (consumables, services) representing ~79% of total revenue
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2024Introduced CytoFLEX Nano Flow Cytometer for biomedical research applications
  • June 2019Acquired Cytobank, a leading cloud-based flow cytometry analysis software platform
Get alerted when Beckman Coulter, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

CepheidMolecular diagnostics and point-of-care testing systems→SartoriusBioprocess solutions and laboratory products→Agilent TechnologiesLife sciences, diagnostics, and analytical instrumentation→IlluminaNext-generation DNA sequencing and genomics solutions→Roche DiagnosticsIn vitro diagnostics and clinical laboratory instruments→

Compare Beckman Coulter, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Beckman Coulter, Inc. operates in In-Vitro Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse In-Vitro Diagnostics research →
NEW · MCP server

Ask your AI assistant about Beckman Coulter, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Beckman Coulter, Inc. and its top competitor on Cyborg Score”
“What did Beckman Coulter, Inc. do this quarter?”
“Is Beckman Coulter, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Beckman Coulter, Inc. do?+
Beckman Coulter, Inc. is a biomedical testing instrument manufacturer and a subsidiary of Danaher Corporation since 2011. The company develops, manufactures, and markets diagnostic and life sciences products including...
What is Beckman Coulter, Inc.'s Cyborg Score?+
Beckman Coulter, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Beckman Coulter, Inc.'s main competitors?+
Named competitors include Cepheid, Sartorius, Agilent Technologies, Illumina. The full competitive landscape is in the AskCyborg report.
How can I get the full Beckman Coulter, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Beckman Coulter, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Beckman Coulter, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More In-Vitro Diagnostics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7DiaSorin S.p.A.7Shenzhen New Industries Biomedical Engineering Co., Ltd.4Biosynex SA7Sartorius Aktiengesellschaft6Illumina, Inc.